China Health Industries Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022
February 13, 2023 at 01:49 pm
Share
China Health Industries Holdings, Inc. reported earnings results for the second quarter and six months ended December 31, 2022. For the second quarter, the company reported sales was USD 0.03265 million compared to USD 0.000002 million a year ago. Net income was USD 0.929303 million compared to net loss of USD 0.573524 million a year ago. Basic earnings per share from continuing operations was USD 0.0142 compared to basic loss per share from continuing operations of USD 0.0088 a year ago. Diluted earnings per share from continuing operations was USD 0.0142 compared to diluted loss per share from continuing operations of USD 0.0088 a year ago.
For the six months, sales was USD 0.03265 million compared to USD 0.000268 million a year ago. Net income was USD 0.472858 million compared to net loss of USD 0.594911 million a year ago. Basic earnings per share from continuing operations was USD 0.0072 compared to basic loss per share from continuing operations of USD 0.0091 a year ago. Diluted earnings per share from continuing operations was USD 0.0072 compared to diluted loss per share from continuing operations of USD 0.0091 a year ago.
China Health Industries Holdings, Inc. is a manufacturer of health food products. The Company's principal business operations are conducted through its subsidiaries: Harbin Humankind Biology Technology Co., Limited (Humankind) and Heilongjiang Huimeijia Pharmaceutical Co., Ltd (HLJ Huimeijia). The Company has three operating segments: Humankind, HLJ Huimeijia and others. Humankind is engaged in the manufacturing and sale of health products. HLJ Huimeijia is engaged in the manufacturing and distribution of tincture; ointments; rubber paste, including hormones; topical solution, suppositories, liniment, including traditional Chinese medicine extractions; enemas, and oral liquids. As of June 30, 2016, the Company, through Humankind manufactured and sold 14 health supplement products. As of June 30, 2016, the Company, through HLJ Huimeijia manufactured and sold 21 products. The Company's products are sold through sales agents.
CHINA HEALTH INDUSTRIES HOLDINGS, INC. 
